Advanced metastatic radioiodine refractory differentiated thyroid cancer: current treatment and dynamic surveillance issues

The patients with progressive metastatic radioiodine refractory differentiated thyroid cancer have a rather unfavorable prognosis. Their life expectancy, according to various authors, does not exceed 3–5 years. To date, tyrosine kinase inhibitors have demonstrated their effectiveness in the treatmen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. V. Borodavina, A. Yu. Shurinov, V. V. Krylov
Formato: Artigo
Lenguaje:Russo
Publicado: ABV-press 2025-03-01
Colección:Опухоли головы и шеи
Materias:
progressive metastatic radioiodine refractory differentiated thyroid cancer
progression
thyroglobulin
response evaluation criteria in solid tumors
targeted therapy
lenvatinib
response to treatment
Acceso en línea:https://ogsh.abvpress.ru/jour/article/view/1041
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares